Adhesion-mediated intracellular redistribution of c-Fas-associated death domain-like IL-1-converting enzyme-like inhibitory protein-long confers resistance to CD95-induced apoptosis in hematopoietic cancer cell lines

被引:96
作者
Shain, KH
Landowski, TH
Dalton, WS
机构
[1] Univ S Florida, Dept Interdisciplinary Oncol, Tampa, FL 33612 USA
[2] Univ S Florida, Dept Biochem & Mol Biol, Tampa, FL 33612 USA
[3] Univ S Florida, H Lee Moffit Canc Ctr & Res Inst, Clin Invest Program, Tampa, FL 33612 USA
关键词
D O I
10.4049/jimmunol.168.5.2544
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Evasion of immune surveillance is a key step in malignant progression. Interactions between transformed hematopoietic cells and their environment may initiate events that confer resistance to apoptosis and facilitate immune evasion. In this report, we demonstrate that beta(1) integrin-mediated adhesion to fibronectin inhibits CD95-induced caspase-8 activation and apoptosis in hematologic tumor cell lines. This adhesion-dependent inhibition of CD95-mediated apoptosis correlated with enhanced c-Fas-associated death domain-like IL-1-converting enzyme-like inhibitory protein-long (c-FLIPL) cytosolic solubility compared with nonadhered cells. Cytosolic c-FLIPL protein preferentially associated with cytosolic Fas-associated death domain protein (FADD) and localized to the death-inducing signal complex after CD95 ligation in adherent cells. The incorporation of c-FLIPL in the death-inducing signal complex prevented procaspase-8 processing and activation of the effector phase of apoptosis. Adhesion to fibronectin increased c-FLIPL cytosolic solubility and availability for FADD binding by redistributing c-FLIPL from a preexisting membrane-associated fraction. Increased cytosolic availability of c-FLIPL for FADD binding was not related to increased levels of RNA or protein synthesis. These data show that adhesion of anchorage-independent cells to fibronectin provides a novel mechanism of resistance to CD95-mediated programmed cell death by regulating the cellular localization and availability of c-FLIPL.
引用
收藏
页码:2544 / 2553
页数:10
相关论文
共 61 条
[1]   ADHESION TO FIBRONECTIN PROLONGS EOSINOPHIL SURVIVAL [J].
ANWAR, ARF ;
MOQBEL, R ;
WALSH, GM ;
KAY, AB ;
WARDLAW, AJ .
JOURNAL OF EXPERIMENTAL MEDICINE, 1993, 177 (03) :839-843
[2]   Matrix attachment regulates Fas-induced apoptosis in endothelial cells: A role for c-Flip and implications for anoikis [J].
Aoudjit, F ;
Vuori, K .
JOURNAL OF CELL BIOLOGY, 2001, 152 (03) :633-643
[3]   ROLE OF INTERLEUKIN-6 IN THE GROWTH OF MYELOMA-DERIVED CELL-LINES [J].
BARUT, BA ;
ZON, LI ;
COCHRAN, MK ;
PAUL, SR ;
CHAUHAN, D ;
MOHRBACHER, A ;
FINGEROTH, J ;
ANDERSON, KC .
LEUKEMIA RESEARCH, 1992, 16 (10) :951-959
[4]   Involvement of MACH, a novel MORT1/FADD-interacting protease, in Fas/APO-1- and TNF receptor-induced cell death [J].
Boldin, MP ;
Goncharov, TM ;
Goltsev, YV ;
Wallach, D .
CELL, 1996, 85 (06) :803-815
[5]   Establishment of a functional human immunodeficiency virus type 1 (HIV-1) reverse transcription complex involves the cytoskeleton [J].
Bukrinskaya, A ;
Brichacek, B ;
Mann, A ;
Stevenson, M .
JOURNAL OF EXPERIMENTAL MEDICINE, 1998, 188 (11) :2113-2125
[6]   Constitutive activation of Stat3 signaling confers resistance to apoptosis in human U266 myeloma cells [J].
Catlett-Falcone, R ;
Landowski, TH ;
Oshiro, MM ;
Turkson, J ;
Levitzki, A ;
Savino, R ;
Ciliberto, G ;
Moscinski, L ;
Fernández-Luna, JL ;
Nuñez, G ;
Dalton, WS ;
Jove, R .
IMMUNITY, 1999, 10 (01) :105-115
[7]  
CHEN QM, 1994, J BIOL CHEM, V269, P26602
[8]   Integrin-mediated drug resistance in multiple myeloma [J].
Damiano, JS ;
Dalton, WS .
LEUKEMIA & LYMPHOMA, 2000, 38 (1-2) :71-81
[9]   Cell adhesion-mediated drug resistance (CAM-DR) protects the K562 chronic myelogenous leukemia cell line from apoptosis induced by BCR/ABL inhibition, cytotoxic drugs, and γ-irradiation [J].
Damiano, JS ;
Hazlehurst, LA ;
Dalton, WS .
LEUKEMIA, 2001, 15 (08) :1232-1239
[10]   Cell adhesion mediated drug resistance (CAM-DR): Role of integrins and resistance to apoptosis in human myeloma cell lines [J].
Damiano, JS ;
Cress, AE ;
Hazlehurst, LA ;
Shtil, AA ;
Dalton, WS .
BLOOD, 1999, 93 (05) :1658-1667